MSOT in lower extremity revascularization (LER)
Dr. med. Tim Wittig and Birte Winther present the results of a clinical study conducted at Leipzig University Hospital in the field of Peripheral Arterial Disease (PAD). This study evaluates the use of MSOT to assess changes in muscle perfusion following endovascular revascularization in PAD patients. Their findings highlight the potential of MSOT as a valuable tool for monitoring microvascular perfusion and thereby treatment efficacy of revascularization. The session offers a deep dive into the study design and results, followed by a Q&A discussion to facilitate professional discourse.
Optoacoustic imaging of muscle degeneration in late-onset Pompe Disease
Dr. med. Ferdinand Knieling from the University Hospital Erlangen presents his group’s groundbreaking pilot study, published in Nature Communications. In this session, Dr. Knieling explores the role of biomarkers in assessing muscle degeneration in Pompe disease and demonstrates the potential of iThera’s optoacoustic imaging technology as a clinical diagnostic tool for neuromuscular diseases. The session features an in-depth discussion of the study results, followed by an engaging Q&A session.
Optoacoustic imaging for disease monitoring
Dr. Hailong He (Helmholtz Center Munich), Dr. Sara di Giulio (Humanitas Research Hospital), and Dr. Dinish U. S (Skin Research Institute of Singapore) present their respective research on non-invasive optoacoustic imaging biomarkers with ultra-broadband raster-scan optoacoustic mesoscopy (RSOM) – an innovative imaging technology that offers advanced optical imaging of the skin with assessment of endothelial function.
Gaining New Insights into PAD and Diabetes Using Optoacoustic Imaging in Clinical Research
Dr. Angelos Karlas (University Hospital rechts der Isar, Technical University Munich) and Dr. Ulrich Rother (University Hospital Erlangen) present their respective work on non-invasive optoacoustic imaging biomarkers for intermittent claudication and the correlation of microangiopathy phenotypes with diabetes stage.
Fast optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo
Dr. Hailong He, Group leader at Technical University of Munich, presents his work on fast high-resolution optoacoustic imaging in human melanoma. He shows how 3D imaging of vascular characteristics in skin lesions could allow diagnostic insights not available by conventional visual inspection.
Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
Dr. Isabel Quiros Gonzalez, Head of the Histopathology Core at the University of Oviedo and previously with Cancer Research UK Cambridge Institute, outlines her work using MSOT (multispectral optoacoustic tomography) to assess response to a vascular-disruptive treatment in a preclinical breast cancer model.
Non-invasive optoacoustic imaging of proteinopathy in mouse models of Alzheimer’s disease
Dr. Ruiqing Ni, group leader at the Institute for Regenerative Medicine, UZH and Institute for Biomedical Engineering, ETH
3D Imaging of Vascular Anomalies Using RSOM
Emily L. Geisler, medical student at the Wertheim College of Medicine, FL, USA.
Optoacoustic Imaging in Dermatology
Dr. Katja Haedicke from iThera Medical, Dr. Andrea Murray from University of Manchester, Dr. Dinish U.S and Dr. Amalina Binte Ebrahim Attia from A*STAR Singapore Bioimaging Consortium and Dr. Juan Aguirre from Technical University Munich.
Optoacoustic Imaging in Inflammatory Bowel Disease
Prof. Dr. med. Maximilian Waldner, Professor of Functional Imaging in Medicine at the University Hospital Erlangen